FAQ/Help |
Calendar |
Search |
Today's Posts |
06-29-2009, 12:50 PM | #1 | ||
|
|||
News Gatherer
Community Support Team
|
HealthDay - MONDAY, June 29 (HealthDay News) -- The immunosuppressive drug golimumab shows promise in treating rheumatoid arthritis patients who don't respond to other drugs, according to a new study. Golimumab is from the family of drugs called tumor necrosis factor-a (TNF-a) inhibitors.
Read the full article... (From Yahoo Diseases) |
||
Reply With Quote |
Reply |
|
|